- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Coya Therapeutics Inc (COYA)
Assess today's live Coya Therapeutics Inc (COYA) share price, performance and insights using our live NASDAQ: COYA stock exchange data.
Analyse the historical data and Coya Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Coya Therapeutics share price buy/sell indicators using real-time data (or discuss the Coya Therapeutics (COYA) stock price today with other investors in the Coya Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ COYA share price (ISIN: US22407B1089) to enhance your trading decisions with our free investment tools and resources.
What Is the Coya Therapeutics Inc Share Price Today?
The Coya Therapeutics share price today is 5.39.
What Is the Stock Symbol for Coya Therapeutics Inc
The stock symbol (or 'ticker') for Coya Therapeutics Inc is "COYA."
What Stock Exchange Does Coya Therapeutics Inc Trade On?
Coya Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Coya Therapeutics Inc a Good Stock to Buy?
Determining whether Coya Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Coya Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Coya Therapeutics share price buy/sell indicators using real-time data (or discuss the Coya Therapeutics (COYA) stock price today with other investors in the Coya Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ COYA share price (ISIN: US22407B1089) to enhance your trading decisions with our free investment tools and resources.
What Is the Coya Therapeutics Inc Share Price Today?
The Coya Therapeutics share price today is 5.39.
What Is the Stock Symbol for Coya Therapeutics Inc
The stock symbol (or 'ticker') for Coya Therapeutics Inc is "COYA."
What Stock Exchange Does Coya Therapeutics Inc Trade On?
Coya Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Coya Therapeutics Inc a Good Stock to Buy?
Determining whether Coya Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.34
5.69
52 wk Range
4.65
8.29
COYA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.345.69
52 wk Range
4.658.29
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
COYA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
16.07
Upside
+198.17%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
- Form 10Q Coya Therapeutics Inc For: 12 November
- Investing.com
- Form 8K Coya Therapeutics Inc For: 12 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Coya Therapeutics Company Profile
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages in Phase 2 trial for use in the treatment of amyotrophic lateral sclerosis, as well as frontotemporal dementia, Alzheimer’s disease (AD), and Parkinson’s disease. In addition, the company’s pre-clinical product candidates include COYA 301, a low-dose interleukin 2 product candidate to treat AD; COYA 303, an investigational biologic combination of COYA 301 and a glucagon-like-peptide-1 receptor agonist for the treatment of inflammatory diseases; COYA 201, an antigen directed Treg-derived exosome product candidate to treat neurodegenerative, autoimmune, and metabolic diseases; COYA 206, an antigen directed Treg-derived exosome product candidate; and COYA 101. It has a collaboration with Dr. Reddy's Laboratories SA for the development and commercialization of COYA 302, an investigational combination therapy for treatment of amyotrophic lateral sclerosis. Coya Therapeutics, Inc. was founded in 2020 and is headquartered in Houston, Texas.
Compare COYA to Peers and Sector
Metrics to compare | COYA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCOYAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.1x | −4.6x | −0.6x | |
PEG Ratio | 0.14 | 0.14 | 0.00 | |
Price/Book | 4.1x | 3.7x | 2.6x | |
Price / LTM Sales | 28.3x | 16.0x | 3.2x | |
Upside (Analyst Target) | 196.8% | 74.0% | 41.8% | |
Fair Value Upside | Unlock | 3.1% | 5.1% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 16.07
(+198.17% Upside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-0.13 / -0.59
Revenue / Forecast
3.56M / --
People Also Watch
FAQ
What Is the Coya Therapeutics (COYA) Share Price Today?
The live Coya Therapeutics share price today is 5.39
What Stock Exchange Does Coya Therapeutics (COYA) Trade On?
Coya Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Coya Therapeutics?
The stock symbol (also called a 'ticker') for Coya Therapeutics is "COYA."
What Is the Current Coya Therapeutics Market Cap?
As of today, Coya Therapeutics market capitalisation is 112.78M.
What Is Coya Therapeutics's (COYA) Earnings Per Share (TTM)?
The Coya Therapeutics EPS is currently -1.11 (Trailing Twelve Months).
When Is the Next Coya Therapeutics Earnings Date?
Coya Therapeutics's next earnings report will be released on 24 Mar 2026.
Is COYA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Coya Therapeutics moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Coya Therapeutics Stock Split?
Coya Therapeutics has split 0 times. (See the COYA stock split history page for full effective split date and price information.)
How Many Employees Does Coya Therapeutics Have?
Coya Therapeutics has 8 employees.
What is the current trading status of Coya Therapeutics (COYA)?
As of 24 Dec 2025, Coya Therapeutics (COYA) is trading at a price of 5.39, with a previous close of 5.36. The stock has fluctuated within a day range of 5.34 to 5.69, while its 52-week range spans from 4.65 to 8.29.
What Is Coya Therapeutics (COYA) Price Target According to Analysts?
The average 12-month price target for Coya Therapeutics is USD16.07143, with a high estimate of USD18 and a low estimate of USD14. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +198.17% Upside potential.
What Is the COYA Premarket Price?
COYA's last pre-market stock price is 5.61. The pre-market share volume is 3,590.00, and the stock has decreased by 0.25, or 4.66%.
What Is the COYA After Hours Price?
COYA's last after hours stock price is 5.41, the stock has decreased by 0.02, or 0.33%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.